![](/img/cover-not-exists.png)
3021 POSTER Association between exposure to bevacizumab (BV) beyond first progression (BBP) and overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): results from a large observational study (BRiTE)
A. Grothey, M. Sugrue, E. Hedrick, D. Purdie, P. Chiruvolu, W. Dong, D. Sargent, M. KozloffVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70949-7
File:
PDF, 76 KB
english, 2007